Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews

Inflamm Bowel Dis. 2019 Feb 21;25(3):472-478. doi: 10.1093/ibd/izy268.

Abstract

A symposium organized by the Cochrane IBD Group and presented at the 2017 Digestive Disease Week annual meeting reviewed the recent literature on several controversial topics in inflammatory bowel disease (IBD) management including the efficacy of oral aminosalicylates for induction and maintenance of Crohn's disease (CD), the feasibility of drug withdrawal in patients with quiescent CD, and strategies for detecting colon cancer in patients with IBD. This article summarizes the data presented at that session.

Keywords: Crohn’s disease; cancer detection; colonoscopy; drug withdrawal; ulcerative colitis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Aminosalicylic Acid / administration & dosage
  • Aminosalicylic Acid / adverse effects*
  • Colitis, Ulcerative / drug therapy*
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / diagnosis*
  • Crohn Disease / drug therapy*
  • Humans
  • Prognosis
  • Withholding Treatment

Substances

  • Aminosalicylic Acid